Каталог стандартов

+7 (495) 223-46-76 +7 (812) 309-78-59
inform@normdocs.ru

ASTM D5022-07

Отменен
Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use (Withdrawn 2014) — 2 стр.
Причина отмены

This specification dealt with identification of small volume containers of drugs intended to be diluted before parenteral administration.

Formerly under the jurisdiction of Committee D10 on Packaging, this specification was withdrawn in May 2014. This standard is being withdrawn without replacement due to its limited use by industry.

Реферат

This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration such as container shape, labeling statements, vial closures and ampoule marking. Drugs in liquid form requiring dilution before parenteral administration shall not be packaged in containers that resemble a normal syringe. The design of such containers shall preclude direct intravenous line injection of the solution. The labels on each container shall bear the words dilute before use. Such black metal closures and black flip-off type caps and use of a black band or series of bands above the contracture on an ampoule shall only be used for Potassium Chloride for Injection Concentrate. With this, identification of such vials and ampoules shall be easy.

Область применения

1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows:

1.1.1 Container shape,

1.1.2 Labeling statements.

1.1.3 Vial closures and Flip-Off, type caps, and

1.1.4 Ampoule marking.

ICS
11.120.10 Medicaments. Including medical prescriptions and medicinal herbs / Медикаменты. Включая медицинские рецепты и лекарственные травы
Сборник ASTM
15.10 Packaging; Primary Barrier Packaging; Cannabis / Упаковка; Первичная барьерная упаковка; Каннабис
Тематика
Paper & Packaging